Development and validation of RP- HPLC method for the determination of Ziprasidone in bulk and pharmaceutical dosage form

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2016, Vol 4, Issue 1

Abstract

A simple, accurate, highly sensitive, efficient, precise and reproducible isocratic reverse phase - high performance liquid chromatographic method was developed and validated for the quantitative analysis of Ziprasidone in pharmaceutical forms. The separation was achieved on Shimadzu LC-20AT Prominence Liquid Chromatograph having a Welchrom C18 isocratic column (250 × 4.6 mm i.d., particle size 5 μm, maintained at ambient temperature) used as stationary phase. Acetonitrile: Water (50:50 v/v), adjusted to pH 3.3 with ortho phosphoric acid, and added drop wise, as mobile phase. The flow rate was set to 1.0 mL/minutes. The wavelength was determined at 251 nm using Shimadzu SPD-20A prominence UV-Vis detector. A well-defined chromatographic peak of Ziprasidone was exhibited with a retention time of 6.707 minutes and tailing factor of 1.11. Linearity was recognized for Ziprasidone in the range of 2-10 μg/mL with correlation coefficient 0.9999.Validation parameters such as specificity, linearity, precision, accuracy, and robustness, limit of detection (LOD) and limit of quantitation (LOQ) were evaluated. The projected methods were validated according to International Conference on Harmonization ICH Q2 (R1) guidelines. The developed method was successfully applied for the quantitative analysis of commercially available dosage form.

Authors and Affiliations

P. Ravisankar, K. Anusha Rani, H. Anusha, V. Himaja, S. Bhavitha, S. Gowthami

Keywords

Related Articles

Ethosomes: novel vesicular carriers for enhanced transdermal drug delivery of candesartan cilexetil

The aim of this research activity is to formulate egg phosphatidyl choline based ethosomes for percutaneous administration of Candesartan cilexetil for the better management against cardiovascular disorders. The IR pea...

Design and development of Metformin hydrochloride Trilayered sustained release tablets

Diabetes is one of the major causes of death and disability in the world. Diabetes results from decreased secretion of insulin, decreased insulin action or both. The main aims of the investigation was to design and dev...

AN ICE-CREAM TYPE PHARMACEUTICAL FORMULATION OF PIPERAZINE HYDRATE AND ITS EVALUATION

The main objective of this work is to develop an ice cream type pharmaceutical formulation of piperazine hydrate and a process for preparing the same to substitute for tablets and syrups. Ice cream type formulations ha...

Formulation and evaluation of chitosan nanoparticles containing Zidovudine for the target delivery into the brain

Chitosan nanoparticles of Zidovudine (AZT), coated with Polysorbate 80 were prepared in the present study. The technique used in the preparation of nanoparticles was spontaneous emulsification. The nanoparticles were p...

Anti-osteoporotic effect of Urtica dioica on ovariectomised rat

This study was undertaken to check the anti-osteoporotic activity of Urtica dioica on ovariectomised (OVX) rats. Bilateral ovariectomy was performed in rats under aseptic condition and ether anaesthesia. Healthy albino...

Download PDF file
  • EP ID EP33365
  • DOI -
  • Views 280
  • Downloads 0

How To Cite

P. Ravisankar, K. Anusha Rani, H. Anusha, V. Himaja, S. Bhavitha, S. Gowthami (2016). Development and validation of RP- HPLC method for the determination of Ziprasidone in bulk and pharmaceutical dosage form. Indian Journal of Research in Pharmacy and Biotechnology, 4(1), -. https://europub.co.uk/articles/-A-33365